Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2023-05-18 Call Transcript
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Orchid Pharma Limited on May 11, 2023, discussing the financial results for the quarter and financial year ended March 31, 2023. It includes management commentary on financial performance, business strategy, product launches, market conditions, and Q&A with investors. The presence of detailed financial figures, management discussion, and Q&A format is characteristic of a Call Transcript (CT). The document is not a brief announcement, regulatory filing, or a report itself but a full transcript of the earnings call event.
2023-05-18 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2023-05-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It discusses actions against promoters for non-compliance with minimum public shareholding requirements, details about share sales, attempts to raise capital via QIP, and requests for regulatory relaxation. It is an announcement to stock exchanges about regulatory compliance status and related corporate actions, not a full financial report or audit. The document length is 3240 characters, relatively short and focused on regulatory disclosure. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-05-17 English
Copy of Newspaper Publication
Regulatory Filings
2023-05-12 English
Updates
Regulatory Filings
2023-05-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a short announcement dated May 11, 2023, informing about the availability of the audio recording of an investor call discussing the audited financial results for the quarter and financial year ended March 31, 2023. It references the call but does not contain the transcript or detailed financial data itself. The document is under 5,000 characters and primarily serves to notify stakeholders about the recording's availability on the company's website. According to the rules, such announcements about the availability of call recordings are classified as Call Transcript (CT) if the transcript is provided, but here only the audio recording link is given. Since it is an announcement of the call recording and not the transcript or detailed financial data, the best fit is Call Transcript (CT) as it relates directly to the earnings call content. Confidence is high due to clear mention of the investor call and audio recording related to financial results.
2023-05-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.